Endoplasmic Reticulum Stress and Disease
Endoplasmic Reticulum Stress and Disease is a research topic within Cell Biology. Science Explorer counts 34k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the molecular mechanisms, regulation, and consequences of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). It explores the role of ER stress in various diseases such as diabetes, cancer, neurodegenerative diseases, and liver disease, highlighting its impact on cell fate decisions, protein folding, oxidative stress, and apoptosis. The cluster also delves into the involvement of UPR pathways, chaperones, and the interplay between ER stress and inflammation.
- Endoplasmic Reticulum
- Stress
- Unfolded Protein Response
- ER Stress
- Cell Death
- Protein Folding
- UPR Pathways
- Oxidative Stress
- Apoptosis
- Chaperones
- Research works
- 34k fractional, since 1950
- In the world top 10%
- 3.3k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +6% the tick is no change
- Largest producer
China
45% of the 10 largest, 2022-now
Which countries lead Endoplasmic Reticulum Stress and Disease research?
By volume, China and the United States publish the most (2.4k and 1.4k works in 2022-now).
By volume, 2022-now
- 1
China 2.4k works
- 2
United States 1.4k works
- 3
Japan 319 works
- 4
India 261 works
- 5
Germany 241 works
- 6
South Korea 191 works
- 7
United Kingdom 181 works
- 8
Italy 164 works
- 9
France 154 works
- 10
Canada 120 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Endoplasmic Reticulum Stress and Disease research?
By volume in 2022-now, Chinese Academy of Sciences publishes the most Endoplasmic Reticulum Stress and Disease research, followed by Sun Yat-sen University and Harvard University.
By volume, 2022-now
- 1
Chinese Academy of Sciences
China 61 works
- 2
Sun Yat-sen University
China 55 works
- 3
Harvard University
United States 55 works
- 4
Shanghai Jiao Tong University
China 53 works
- 5
Zhejiang University
China 49 works
- 6
Huazhong University of Science and Technology
China 42 works
- 7
Wuhan University
China 41 works
- 8
Centre National de la Recherche Scientifique
France 41 works
- 9
Sichuan University
China 40 works
- 10
Central South University
China 40 works
Who are the leading researchers in Endoplasmic Reticulum Stress and Disease?
The most-cited researchers publishing on Endoplasmic Reticulum Stress and Disease include Eric S. Lander, Mark J. Daly and Peer Bork.
- 1
Eric S. Lander
United States 524k citations
- 2
Mark J. Daly
United States 403k citations
- 3
Peer Bork
Germany 396k citations
- 4
Guido Kroemer
France 386k citations
- 5
Gad A. Getz
United States 364k citations
- 6
Shizuo Akira
Japan 342k citations
- 7
Jun Wang
China 340k citations
- 8
Giuseppe Remuzzi
Italy 328k citations
- 9
Matthias Mann
Germany 308k citations
- 10
Richard A. Gibbs
United States 292k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Endoplasmic Reticulum Stress and Disease research done?
The largest centres of Endoplasmic Reticulum Stress and Disease research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China).
Where is the best place to study Endoplasmic Reticulum Stress and Disease?
Among universities, judged by research, Harvard University, Zhejiang University and Sun Yat-sen University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Endoplasmic Reticulum Stress and Disease, country by countryIs Endoplasmic Reticulum Stress and Disease research growing?
Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Endoplasmic Reticulum Stress and Disease.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Endoplasmic Reticulum Stress and Disease as a percentage of every work published that year, 0.027% in 2024.
Fractional works of Endoplasmic Reticulum Stress and Disease over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Endoplasmic Reticulum Stress and Disease. Posts are plain text and can be reported.